Shanghai Genomics was selected at the 2019 China Pharmaceutical Formulation Conference (2019中国药物制剂大会)as one of the “The Chinese Technologically Innovative Pharmaceutical Companies with the Most Growth Potential of 2019” (2019年中国最具成长力科技创新型医药企业)